MedPlast Closes Acquisition and Rebrands as Viant

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

MedPlast, LLC announced today (July 9, 2018) that the company has completed its previously announced acquisition of Integer Holding Corporation’s Advanced Surgical and Orthopedics (“AS&O”) business. MedPlast also announced that it will rebrand under the name, Viant, to reflect the company’s new strategic direction.

“Today marks an exciting day for our company.  The addition of Integer’s business expands our capabilities and offerings, and enables us to achieve our goal of being a full-service supplier to our customers,” said MedPlast Chief Executive Officer Brian King.  “Our new name, Viant, represents our dedication to our customers and to the patients that our customers serve; and is indicative to our commitment that ‘we’re in it for life.’ We could not be more pleased to rebrand as Viant in conjunction with the close of this newest acquisition.”

MedPlast has bolstered its portfolio of end-to-end solutions in the medical technology space with three acquisitions in the past 15 months. With the company’s most recent acquisition of Integer’s AS&O business, MedPlast doubles in size to nearly $1 billion in sales, expands its metals capabilities and extends its global footprint into Europe. The acquisition also strengthens MedPlast’s ability to vertically integrate and simplify the supply chain for its customers.

In addition to rebranding as Viant, MedPlast announced that its corporate headquarters will move to Foxborough, Massachusetts, placing it in a major medical device hub near many of its customers. Since Water Street and JLL’s investment in MedPlast in 2016, the company’s employee base has doubled to nearly 6,000 associates located across the United States, Central America, Europe, and Asia.



Related Articles